Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2024-03-29 00:00:00 ET · period of report 2024-03-29 · accession 0001714899-24-000097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-03-29 | 2024-03-29 | DNLI | Watts Ryan J. | Pres, CEO, Dir | G - Gift | $0.00 | -40.0K | 2.20M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-29 | G | D | 40,000 | $0.00 | 2,202,604 | I See footnote | — | — | (F1) Reflects an in-kind charitable contribution of 40,000 shares of DNLI to a donor advised fund. (F2) The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee. |